The BLA could be resubmitted but it would take goi

The BLA could be resubmitted but it would take going back to primary sources and collecting all the data. Then compiling all that data again for a difficult to do BLA since it uses data from two different trials. Given that the FDA is asking for a new HIV trial protocol they may reject that BLA submission out of hand without even looking at it.